{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-24-000069","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.469648+00:00","generated_at":"2026-06-01T22:40:23.017164+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Elevance Health shareholders elect directors, approve executive pay, ratify E&Y, reject political spending proposal","bullets":["Lewis Hay, III, Antonio F. Neri, and Ramiro G. Peru were elected as directors for three-year terms with over 183 million votes each.","Advisory vote on executive compensation approved with 179,754,212 for and 15,863,613 against.","Ratification of Ernst & Young LLP as independent auditor for 2024 passed with 186,378,524 votes for.","Shareholder proposal on annual political activity reporting rejected with only 9,977,190 votes in favor."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-24-000069","json":"https://secwatch.observer/filing/0001156039-24-000069.json","markdown":"https://secwatch.observer/filing/0001156039-24-000069.md","text":"https://secwatch.observer/filing/0001156039-24-000069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/0001156039-24-000069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/axsubmissionofmatterstoavo.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:40:23.017164+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0532d9b840fd35970b68d2284e4484762a783bf1","claim":"Elevance Health, Inc. shareholders approved Advisory vote on the Company’s executive compensation at the 2024-05-15 meeting.","evidence_excerpt":"Advisory vote on the Company’s executive compensation. The advisory vote on the compensation of the Company’s named executive officers was approved based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/0001156039-24-000069-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-15"}],"fact_type":"shareholder_vote"},{"claim_id":"05e9e3ecef11343c4192e7be6c972dc1c926a218","claim":"Elevance Health, Inc. shareholders rejected Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations at the 2024-05-15 meeting.","evidence_excerpt":"Shareholder proposal requesting annual political activity reporting from certain third parties prior to the Company donating to the organizations. The shareholder proposal requesting annual political activity reporting from third parties prior to the Company donating to the organization was not approved based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/0001156039-24-000069-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2024-05-15"}],"fact_type":"shareholder_vote"},{"claim_id":"480d8aa77158b0f2d4e0838374a90bb40d6e5544","claim":"Elevance Health, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.","evidence_excerpt":"Election of Directors. The following nominees for director were elected to serve three-year terms to expire at the Company’s annual meeting of shareholders in 2027 based on the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/0001156039-24-000069-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-15"}],"fact_type":"shareholder_vote"},{"claim_id":"56f2326b26c149f1ee3b0cdce03b0a20a7f5e5e6","claim":"Elevance Health, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP at the 2024-05-15 meeting.","evidence_excerpt":"Ratification of the appointment of Ernst & Young LLP. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2024 was ratified based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000069/0001156039-24-000069-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}